The Synergistic Anticancer Effect of Dual Drug- (Cisplatin/Epigallocatechin Gallate) Loaded Gelatin Nanoparticles for Lung Cancer Treatment

Figure 7

Cell viability of A549 cells treated with single (GE) or dual drug- (GE-Pt) loaded NPs on day 1, day 3, and day 7 at low concentration (GE with EGCG at 5 μg/mL or GE-Pt with EGCG at 5 μg/mL combined with cisplatin at 2 μg/mL). ^∧, GE-treated cells compared with GE day 1, ^#, GE-Pt-treated cells compared with GE-Pt day 1, and , GE-Pt compared with GE.